For decades, the mention of "palliative care" in an oncology ward has been met with a quiet, pervasive tension. Often mistakenly siloed as a synonym for hospice or end-of-life care, palliative medicine has long suffered from a branding crisis that prevents it from reaching the patients who need it most. However, a growing movement of clinical experts and advocates is working to dismantle this misconception, arguing that palliative care and psychosocial support should not be a final resort, but a foundational pillar of cancer treatment from the moment of diagnosis.
Susan Hedlund, MSW, LCSW, FAOSW, Director of Supportive Care Initiatives at the Sheri and Les Biller Family Foundation, stands at the vanguard of this paradigm shift. With a career spanning decades in oncology social work and national advocacy, Hedlund is pushing for a systemic migration of supportive care—moving it "upstream" to become an integrated, longitudinal component of the cancer continuum.
Main Facts: The "Whole Person" Imperative
The core of Hedlund’s argument is that cancer is a biopsychosocial event. While medical oncology focuses on the eradication of malignancy through chemotherapy, immunotherapy, or surgery, the patient’s experience is frequently defined by the collateral damage to their emotional, financial, and existential well-being.
"We have to stop viewing palliative care as a ‘death’ conversation," Hedlund notes. "When we integrate it early, we aren’t talking about dying; we are talking about living—about managing symptoms, mitigating side effects, and maintaining quality of life so that the patient can actually tolerate the curative or life-extending treatments they are receiving."
The integration Hedlund proposes includes:
- Early Symptom Management: Proactive management of pain, fatigue, and nausea to ensure treatment adherence.
- Psychosocial Resilience: Providing access to social workers and counselors who help navigate the "new normal" of a cancer diagnosis.
- Care Coordination: Aligning the clinical team with the patient’s personal goals and values, ensuring that the treatment plan aligns with their life priorities.
Chronology: The Evolution of Supportive Care
To understand why this shift is necessary, one must look at how oncology has evolved over the last 40 years.
The 1980s and 90s: The Silo Era
During the late 20th century, oncology was heavily focused on the biological battle. Palliative care was largely confined to inpatient hospice units. Psychosocial support was often relegated to peripheral community organizations, rarely integrated into the hospital’s clinical workflow.
The 2000s: Recognizing the Gap
As cancer survival rates improved, the field began to realize that "survivorship" brought its own set of challenges. Studies began to show that patients with high symptom burdens were less likely to finish their treatment protocols. The term "supportive care" began to gain traction, though it remained largely reactionary rather than proactive.
2010 to Present: The "Upstream" Movement
Landmark studies, such as the 2010 New England Journal of Medicine trial by Temel et al., provided empirical evidence that early palliative care actually improved quality of life and, in some cases, extended survival for patients with metastatic non-small-cell lung cancer. This sparked a global debate on how to embed these services into standard oncology practice. Today, the focus has shifted from whether we should offer early support to how to implement it at scale across diverse, resource-constrained settings.
Supporting Data: The Clinical and Economic Case
The resistance to early palliative care often stems from a misunderstanding of its cost and resource requirements. However, the data paints a compelling picture of efficacy.
Quality of Life Metrics
Research consistently indicates that patients who receive early psychosocial and palliative interventions report lower levels of anxiety and depression. A meta-analysis published in the Journal of Clinical Oncology demonstrated that early integration led to a significant reduction in symptom burden, which directly correlates with higher adherence to systemic therapy. If a patient is not suffering from uncontrolled nausea or unmanaged pain, they are more likely to stay on schedule with their chemotherapy, leading to better clinical outcomes.
Healthcare Utilization
Critics often fear that adding supportive care teams increases costs. Conversely, the evidence suggests that proactive care reduces the "revolving door" of the emergency room. By addressing symptom management in the clinic, oncologists see fewer patients presenting at the ER with unmanaged treatment side effects. This not only improves the patient experience but also reduces the burden on acute care facilities and lowers the total cost of care.
Official Responses and Clinical Perspectives
The medical community is increasingly responding to the call for integration. The American Society of Clinical Oncology (ASCO) has updated its guidelines to explicitly recommend that patients with advanced cancer receive dedicated palliative care services early in the disease course, ideally within eight weeks of diagnosis.
However, implementation remains the primary hurdle. "The challenge is not the ‘what’ or the ‘why’ anymore," Hedlund explains. "It is the ‘how’."
Practical Strategies for Implementation
Hedlund’s work at the Biller Family Foundation centers on bridging the gap between guideline recommendations and clinical reality. Her strategies include:
- Universal Screening: Implementing mandatory psychosocial distress screening at every visit, ensuring no patient falls through the cracks.
- Multidisciplinary Tumor Boards: Including social workers and palliative care clinicians in the initial planning sessions for new cancer cases.
- Advanced Care Planning (ACP) as Standard: Normalizing conversations about treatment goals early, rather than waiting for a crisis or a transition to end-of-life care.
"When we talk about the ‘whole person,’" Hedlund says, "we are acknowledging that a patient is not just a collection of cells. They are a parent, a worker, a member of a community. When their quality of life improves, their ability to navigate their medical journey improves exponentially."
Implications: The Future of "Whole Person" Oncology
The movement to shift palliative and psychosocial care upstream has profound implications for the future of healthcare.
For the Healthcare System
If the medical industry successfully transitions to a "whole person" model, we may see a fundamental restructuring of oncology departments. This means moving away from the "physician-centric" model toward a "team-based" approach, where the social worker, the nutritionist, the psychologist, and the palliative care specialist are as vital to the care plan as the surgeon.
For the Patient Experience
For the patient, the impact is immeasurable. The fear of a cancer diagnosis is compounded by the fear of losing one’s identity to the disease. By integrating supportive care early, the healthcare system acknowledges the patient’s humanity. It transforms the experience from one of passive endurance to one of active, supported engagement.
For Policy and Advocacy
The ongoing challenge remains reimbursement and staffing. As Hedlund points out, national advocacy must focus on incentivizing hospitals to prioritize supportive care services. This involves lobbying for insurance coverage models that value outcomes like "quality of life" and "treatment adherence" as highly as "tumor shrinkage."
Conclusion: A New Standard of Care
The misconception that palliative care is synonymous with end-of-life care is not merely an outdated belief; it is a clinical barrier that denies patients the support they deserve. As Susan Hedlund and her colleagues continue to demonstrate, the integration of palliative and psychosocial support is not an "add-on" or a "luxury"—it is a necessity for high-quality, effective cancer care.
Moving these services upstream represents a shift from a reactive, crisis-driven model to a proactive, patient-centered framework. By embracing this "whole person" approach, oncology can move beyond the metrics of survival toward the goal of providing a dignified, managed, and supported journey for every individual facing a cancer diagnosis. The future of oncology is not just about extending life; it is about ensuring that every day of that life is lived with the support, clarity, and comfort that modern medicine is capable of providing.
As we look toward the next decade of oncology, the measure of success will not only be the survival statistics, but the stories of patients who felt seen, heard, and supported from the very first day of their journey. The path forward is clear: integrate, support, and sustain.
About the Author
